跳至主要内容
临床试验/NCT00681590
NCT00681590已完成3 期

Safety of Vitamin D Supplementation in the Elderly

University of Miami2 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
105
试验地点
2
主要终点
Number of Participants Who Develop Hypercalcemia

研究概览

简要总结

This study will evaluate the safety over 6 months of two different doses of vitamin D (cholecalciferol) in men and women age 65 and older. It will also evaluate if supplementation with vitamin D improves physical performance.

详细描述

120 ambulatory men and women ages 65 to 95 will be enrolled in this study. Each subject will participate in the clinical trial for 6 months.

Parathyroid hormone, vitamin D, and serum and urinary calcium will be measured periodically. Physical performance will be tested at baseline and throughout the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 95 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • ambulatory

排除标准

  • hypercalcemia
  • hypercalciuria > 4 mg/kg body weight/day
  • primary, secondary, or tertiary hyperparathyroidism
  • renal insufficiency (serum creatinine > 2 mg/dL )
  • history of nephrolithiasis
  • treatment with vitamin D (ergocalciferol, cholecalciferol, calcitriol)
  • treatment with anticonvulsants
  • Paget's disease
  • severe cardiac, pulmonary, hepatic, renal, or neurological disease
  • life expectancy < 1 year
  • participation in another trial

结局指标

主要结局

Number of Participants Who Develop Hypercalcemia

时间窗: 6 months

calcium serum levels measured at baseline and at the end of the intervention (6-months)

次要结局

  • Change From Baseline in Serum 25-hydroxyvitamin D Levels(baseline and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Silvina Levis, MD

Professor

University of Miami

研究点 (2)

Loading locations...

相似试验